(Q34182994)

English

Short-term treatment with novel ribonucleotide reductase inhibitors Trimidox and Didox reverses late-stage murine retrovirus-induced lymphoproliferative disease with less bone marrow toxicity than hydroxyurea

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Short-term treatment with novel ribonucleotide reductase inhibitors Trimidox and Didox reverses late-stage murine retrovirus-induced lymphoproliferative disease with less bone marrow toxicity than hydroxyurea (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

hydroxycarbamide

1 reference

based on heuristic

inferred from title

author name string

C N Mayhew

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J D Phillips

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M L Cibull

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

H L Elford

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

V S Gallicchio

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Antiviral Chemistry & Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

305-314

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Bone marrow macrophage iron grade and survival of HIV-seropositive patients

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Treatment of human immunodeficiency virus infection with hydroxyurea: virologic and clinical evaluation

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

The HYDILE trial: efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinations

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

The role of oxidative stress in HIV disease

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Combination therapy with hydroxyurea versus without hydroxyurea as first line treatment options for antiretroviral-naive patients.

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa's HIV/AIDS problem?

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection.

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Immune Restoration by Combination of a Cytostatic Drug (Hydroxyurea) and Anti-HIV Drugs (Didanosine and Indinavir)

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Inhibition of Murine AIDS by Reduced Glutathione

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300506

21 January 2018

Identifiers

10.1177/095632020201300506

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34182994&oldid=1583572178"